-
Company News for December 21, 2009 - Corporate Summary
Monday, December 21, 2009 - 10:17am | 205• Pfizer (NYSE:PFE) purchased rights to Athersys' (NASDAQ:ATHX) stem-cell therapy for treatment of inflammatory bowel disease • Terex (NYSE:TEX) plans to sell its mining business for $1.3 billion in cash to Bucyrus International (NASDAQ:BUCY) • Sanofi-Aventis (NYSE:SNY) said it agreed to buy...
-
Benzinga’s Top Pre- Market Gainers (CHTT, BUCY, SGEN, INCY, MAIL, ATHX)
Monday, December 21, 2009 - 9:25am | 357Chattem Inc. (NASDAQ: CHTT) has jumped 32% to $92.96 after Sanofi-Aventis SA (ADR) (NYSE: SNY) announced that it has agreed to acquire Chattem Inc. (CHTT) for $1.9 billion in cash, or $93.50 a share. The 52-week trading range for CHTT is $50.10 - $71.95. In the last trading session, CHTT closed at...
-
Benzinga’s News Roundup (AIG, ATHX, NOK, INTC, SNY, WAG, CAG)
Monday, December 21, 2009 - 9:06am | 514American International Group, Inc. (NYSE: AIG) CEO Robert Benmosche, today said that AIG needs at least two years to repay the aid it received from the government. AIG is currently trading at $28.18, decreased by 0.04%. The 52-week trading range for AIG is $6.60 - $55.90. In the last trading...
-
Sanofi-Aventis Buying Chattem For $93.50 A Share
Monday, December 21, 2009 - 8:23am | 135Sanofi-aventis (NYSE: SNY) and Chattem, Inc. (Nasdaq: CHTT) announced today that they have entered into a definitive agreement under which sanofi-aventis is to acquire 100 percent of the outstanding shares of Chattem in a cash tender offer for $93.50 per share, or approximately $1.9 billion. The...
-
Morgan Stanley Downgrades Alberto-Culver (ACV)
Thursday, December 17, 2009 - 12:10pm | 80Morgan Stanley downgraded Alberto-Culver Company (NYSE: ACV) from Overweight to Equal-weight rating. The reason for this downgrade for the Alberto-Culver Company is: 1) A recent run-up in the stock that left only an 8% additional upside to its price target of $32, which has not been changed 2) The...
-
Barclays Finds Avon (AVP) To Have Strong Organic Sales Momentum
Tuesday, December 15, 2009 - 4:52pm | 56Barclays has given a 12-month price target of $40 for Avon Products, Inc. (NYSE: AVP). It expects Avon to have strong organic sales momentum driven by positive volume growth. The stock is trading at $33.69 and Barclays believes Avon has considerable room for posting organic sales growth above...
-
Staples Industry May Outperform The Market (CL, EL, KO, PG, PM)
Tuesday, December 15, 2009 - 3:14pm | 308Analysts at Goldman Sachs maintain their “neutral” rating on the Consumer Staples sector in 2010. However, the sector is expected to perform in-line with the broader market. According to Goldman Sachs, the Staples industry may marginally outperform the market in the current stage of the cycle....
-
Barron’s: Insider Stock Transactions
Monday, December 7, 2009 - 3:13pm | 227For the week ended 30 November 2009, the following were insider purchases: 100,000 shares in DirecTV (NASDAQ: DTV), 91,500 shares in Werner Enterprises (WERN), 100,000 shares in Zions Bancorporation (NASDAQ: ZION), 30,500 shares in Rofin Sinar Technologies (NASDAQ: RSTI), 2,774,306 shares in Fusion...
-
Sales of BARE Continue To Be Weak
Monday, December 7, 2009 - 2:42pm | 118Analysts at Goldman Sachs downgrade Bare Escentuals Inc (NASDAQ: BARE) from “neutral” to “sell,” while reducing their estimates for the company. The target price for BARE has been reduced from $12 to $11. Goldman Sachs expects BARE to post flat sales for both 4Q09 and 2010. Recent US retail sales...
-
Benzinga’s Top Downgrades (ZLC, BARE, KMB, CL, AVP, CREE)
Monday, December 7, 2009 - 11:17am | 201Zale Corporation (NYSE: ZLC) has declined 15.73% to $4.17 in the morning session after Soleil Securities downgraded ZLC to from Hold to Sell with a Price target of $2.50. Bare Escentuals, Inc. (NASDAQ: BARE) fell 3.90% to $12.80 after Goldman Sachs downgraded Bare Escentuals from Neutral to Sell...
-
Benzinga’s Volume Movers (SEED, CAAS, CSGS, IPAR, MKTX)
Monday, November 30, 2009 - 4:21pm | 196Some of the stocks seeing extraordinary trading and worth having a look are: Origin Agritech Limited (NASDAQ: SEED) shares appreciated by 17.36% to $12.91. The volume of SEED shares traded in today's session was 742% higher than normal. SEED shares created a new high in more than two years after...
-
Fast Money Picks For November 25th (F, ABT, BSX, BRCD)
Tuesday, November 24, 2009 - 7:47pm | 124CNBC's Fast Money Tim Seymour thinks that investors should take profits in Ford (NYSE: F) because it typically fails at $9. Ford (F) gained 0.92% today and closed at $8.81. Guy Adami recommends buying Abbott Laboratories (NYSE: ABT), and Karen Finerman suggests buying Boston Scientific (NYSE: BSX)...
-
Benzinga’s Top Upgrades (UBSI, DRH, CRM, ADI, IPAR, HTZ, TCB, LKFN)
Tuesday, November 24, 2009 - 11:08am | 340United Bankshares, Inc. (NASDAQ: UBSI) was today upgraded by Boenning & Scattergood from Neutral to Out Perform at a price target of $20.50. UBSI is now trading at $17.94, 3.58% up. UBSI declined by around 45% so far in 2009. DiamondRock Hospitality Company (NYSE: DRH) climbed 2.61% to $8.65 in...
-
Payment Disparity Between The Ceo And The Ordinary Employee: An American Story
Monday, November 23, 2009 - 2:19pm | 251America's top CEOs are getting pay hikes 5 times as fast as the lowly John Qs, even while the economy is sliding down to a point where the US economy is not the best among equals anymore. While the average CEO earned $10.9 million last year,the average wage of a full-time US worker reached $52,916...
-
Volume Talks: Hot Stocks on Heavy Volume & Detailed Buy Write Option Trade
Wednesday, November 18, 2009 - 10:01am | 1787Here is a list of stocks which traded higher Tuesday November 17, 2009 on unusually higher volume. As always, I will keep an eye on these stocks Wednesday to see if there is continued buying pushing the stocks higher. This method is just one of the ways I use to pick stocks to structure...